(Q52973999)

English

Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis.

scientific article published in March 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25606692

Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25606692

1 reference

based on heuristic

inferred from title

pulmonary hypertension

1 reference

based on heuristic

inferred from title

author name string

Adrian J Gilbane

1

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25606692

Emma Derrett-Smith

2

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25606692

Sarah L Trinder

3

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25606692

Robert B Good

4

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25606692

Andrew Pearce

5

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25606692

Christopher P Denton

6

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25606692

Alan M Holmes

7

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25606692

language of work or name

0 references

publication date

1 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25606692

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25606692

191

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25606692

6

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25606692

665-677

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25606692

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Clinical differences between idiopathic and scleroderma-related pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Targeting TGFβ superfamily ligand accessory proteins as novel therapeutics for chronic lung disorders

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Smurf1 ubiquitin ligase causes downregulation of BMP receptors and is induced in monocrotaline and hypoxia models of pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

BMP type II receptor deficiency confers resistance to growth inhibition by TGF-β in pulmonary artery smooth muscle cells: role of proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Gut fibrosis with altered colonic contractility in a mouse model of scleroderma.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Endothelial injury in a transforming growth factor β-dependent mouse model of scleroderma induces pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Fibroblast-specific Expression of a Kinase-deficient Type II Transforming Growth Factor β (TGFβ) Receptor Leads to Paradoxical Activation of TGFβ Signaling Pathways with Fibrosis in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

A novel murine model of severe pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Inhibition of overactive transforming growth factor-β signaling by prostacyclin analogs in pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Activin-like kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by mo

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Alterations in TGF-beta1 expression in lambs with increased pulmonary blood flow and pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Dysfunctional Smad Signaling Contributes to Abnormal Smooth Muscle Cell Proliferation in Familial Pulmonary Arterial Hypertension

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Proteasomal inhibition after injury prevents fibrosis by modulating TGF-β(1) signalling

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201408-1464OC

21 January 2018

Identifiers

10.1164/RCCM.201408-1464OC

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25606692

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25606692

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52973999&oldid=1532219191"